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Mitochondrial outer membrane permeabilization (MOMP) is essential to initiate
mitochondrial apoptosis. Due to the disruption of mitochondrial outer membrane
integrity, intermembrane space proteins, notably cytochrome c, are released into
the cytosol whereupon they activate caspase proteases and apoptosis. Beyond its
well-established apoptotic role, MOMP has recently been shown to display potent
pro-inflammatory effects. These include mitochondrial DNA dependent activation of
cGAS-STING signaling leading to a type I interferon response. Secondly, via an IAP-
regulated mechanism, MOMP can engage pro-inflammatory NF-κB signaling. During
cell death, apoptotic caspase activity inhibits mitochondrial dependent inflammation.
Importantly, by engaging an immunogenic form of cell death, inhibiting caspase function
can effectively inhibit tumorigenesis. Unexpectedly, these studies reveal mitochondria
as inflammatory signaling hubs during cell death and demonstrate its potential for
therapeutic exploitation.
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INTRODUCTION
Mitochondrial outer membrane permeabilization (MOMP), induced by the pro-apoptotic Bcl-2
proteins BAX and BAK, is the essential step in initiating mitochondrial apoptosis. Following
MOMP, soluble mitochondrial intermembrane space proteins including cytochrome c, SMAC
(also called DIABLO) and Omi (also called HtrA2), are released into the cytoplasm. In the
cytoplasm, cytochrome c binds to APAF-1; this leads to APAF-1 conformational changes and
oligomerization into a heptameric wheel-like structure called the apoptosome that recruits and
activates the initiator caspase-9 (Bratton and Salvesen, 2010). Active caspase-9 cleaves and activates
the executioner caspases-3 and -7, leading to widespread substrate cleavage. Caspase activity is
essential for the biochemical and morphological hallmarks of apoptosis, leading to rapid cell
death that is considered immunosilent (Arandjelovic and Ravichandran, 2015). Nevertheless, cells
usually die irrespective of caspase activation upon MOMP, demarcating it as a point of no return
(Tait et al., 2014).
While apoptosis is considered a silent form of cell death, mitochondrial dysfunction (that occurs
upon MOMP) is associated with inflammatory effects. For instance, mitochondrial dysfunction
can lead to cytosolic exposure of several danger-associated molecular patterns (DAMPs), such as
mitochondrial DNA (mtDNA) (Shimada et al., 2012; West et al., 2015) and cardiolipin (Tuominen
et al., 2006). Moreover, mitochondrial ROS – increased upon disruption of mitochondrial
respiratory chain function – can also promote inflammation (Nakahira et al., 2011; Zhou et al., 2011;
Zorov et al., 2014). Once exposed to the cytosol, mitochondrial DAMPs are recognized by various
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adaptor molecules or receptors leading to an inflammatory
response (Grazoli and Pugin, 2018). When mtDNA is in the
cytosol it can be recognized by cyclic GMP-AMP (cGAMP)
synthetase (cGAS), toll-like receptor 9 (TLR9), and the NLRP3
inflammasome (West and Shadel, 2017), of which the latter
can also be activated by mtROS (Shimada et al., 2012). Upon
MOMP, release of intermembrane space proteins (Liu et al., 1998;
Adrain et al., 2001; van Loo et al., 2002) and cytosolic exposure
of the inner mitochondrial membrane occurs (McArthur et al.,
2018; Riley et al., 2018), enabling mtDAMP exposure during
apoptosis. Various studies have shown that activation of apoptotic
caspases has an immunosilencing effect during cell death. The
anti-inflammatory effects of apoptotic caspases are likely to be
pleiotropic; for instance, caspases have been shown to directly
cleave and inactivate inflammatory pathway components as well
as strongly suppress protein translation (Clemens et al., 2000;
Ning et al., 2019). At least two parallel inflammatory pathways
are activated during caspase-independent cell death (CICD)
(Rongvaux et al., 2014; White et al., 2014; Giampazolias et al.,
2017; McArthur et al., 2018; Riley et al., 2018). In this minireview,
we will discuss how MOMP induces inflammation, focusing
primarily on two recently described mechanisms: MOMP-
induced cGAS-STING signaling (Rongvaux et al., 2014; White
et al., 2014; Giampazolias et al., 2017; McArthur et al., 2018; Riley
et al., 2018) and activation of pro-inflammatory NF-κB signaling
(Giampazolias et al., 2017).
MITOCHONDRIAL RELEASE OF mtDNA
CAUSES A TYPE I INTERFERON
RESPONSE
When pathogen-derived, cellular or mitochondrial DNA is
present in the cytosol various immunogenic pathways are
activated. One of these cytosolic DNA sensors is cGAS, which
produces cGAMP, from ATP and GTP, upon DNA binding.
cGAMP functions as a secondary messenger and binds to the
endoplasmic reticulum (ER) membrane adaptor STING (Cai
et al., 2014). Upon binding, STING changes its conformation and
becomes activated. Active STING translocates from the ER to
an ER-Golgi intermediate apparatus and the Golgi compartment.
During this process, the carboxyl terminus of STING recruits and
activates TBK1, which in turn phosphorylates the transcription
factor IRF3. Phosphorylated IRF3 dimerises and translocates
to the nucleus where it initiates a type I interferon response
(Chen et al., 2016). The type I interferon response acts in
a pleiotropic manner to activate both innate and adaptive
immunity (Trinchieri, 2010).
Several years ago, it was found that during mitochondrial
apoptosis under caspase-inhibited conditions a type I interferon
response is activated (Figure 1; Rongvaux et al., 2014; White et al.,
2014). Genetically engineered mouse models and corresponding
mouse embryonic fibroblasts with deleted caspases-3 and -7, or -
9 showed significantly upregulated type I interferon expression
and interferon-stimulated gene response following MOMP.
Consistent with this, cells were highly resistant to infection by
RNA and DNA viruses (Rongvaux et al., 2014). Similar results
were obtained in hematopoietic stem cells, as deletion of caspase
9 increased basal levels of type I interferons and cell death in
the presence of caspase inhibition stimulated expression of type
I interferons (White et al., 2014). Both groups established that
this increase in type I interferons during cell death was due
to recognition of mtDNA by cGAS and subsequently STING
activation (Rongvaux et al., 2014; White et al., 2014).
During mitochondrial apoptosis, only the outer mitochondrial
membrane was thought to permeabilise following BAX and
BAK activation. This made it challenging to reconcile how
matrix localized mtDNA could activate cytosolic cGAS-
STING signaling. Toward answering this conundrum, recent
studies have shown that subsequent to MOMP, the inner
mitochondrial membrane is extruded through expanding,
BAX/BAK-dependent, outer membrane pores (McArthur et al.,
2018; Riley et al., 2018; Ader et al., 2019). In the cytosol, these
mitochondrial herniations can rupture, enabling mtDNA release
(McArthur et al., 2018; Riley et al., 2018). Beyond providing a
mechanism for mtDNA dependent activation of cGAS-STING
signaling these studies demonstrate that BAX and BAK can
form huge, expanding pores, termed macropores (McArthur
et al., 2018), on the mitochondrial outer membrane. Previous
studies have shown that BAX and BAK pores are highly flexible
and dynamic in their pore size and shape in order to release
proteins into the cytosol (Bleicken et al., 2013; Große et al., 2016;
Salvador-Gallego et al., 2016), however, no study had shown
before that these pores could be big enough to release mtDNA
from the mitochondria. It is unclear beyond the requirement for
BAX/BAK activation whether the release of mtDNA is regulated,
but it is independent of both mitochondrial dynamics and
mitochondrial permeability transition (Riley et al., 2018).
Besides STING activation, other immune sensing pathways
can also be activated by mtDNA. Many antigen presenting cells
possess TLR9, which is able to recognize mtDNA by virtue of
its high content of CpG rich domains. It has been observed
that recognition of mtDNA by TLR9 can both lead to NF-κB
translocation and a type I interferon response (Oka et al., 2012;
Zhang et al., 2014; Saito et al., 2018). An immune response can
also be provoked by activation of the NLRP3 inflammasome
via mtDNA during cell death (Nakahira et al., 2011; Shimada
et al., 2012; Vince et al., 2018). Activation of the NLRP3
inflammasome leads to processing of interleukin (IL) 1β and IL-
18, thereby activating monocytes, macrophages, neutrophils, and
T-cells (Netea et al., 2010). Nevertheless, the contribution of these
two pathways in the immune response following CICD awaits
further investigation.
ACTIVATION OF PRO-INFLAMMATORY
NF-κB SIGNALING FOLLOWING MOMP
In addition to increased expression of type I interferon genes
during CICD, we also observed nuclear translocation of NF-
κB, thereby activating transcription of pro-inflammatory genes
(Giampazolias et al., 2017). NF-κB has been described as
having a key role in inflammation, and can be activated
in a canonical and non-canonical manner (Lawrence, 2009).
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FIGURE 1 | Release of mitochondrial proteins and mtDNA initiates an inflammatory response in CICD. Upon an apoptotic trigger, BAX and BAK form pores in the
mitochondrial membrane to allow the release of mitochondrial proteins, such as cytochrome c and SMAC/DIABLO, and mtDNA. During CICD, the release of
mitochondrial proteins activates the NF-κB pathway via a SMAC-like mechanism. In parallel, release of mtDNA may activate the NLRP3 inflammasome, TLR9
receptor and the cGAS-STING pathway. Activation of the latter will lead to nuclear translocation of IRF3 during CICD. Both NF-κB and IRF3 engage the transcription
of various inflammatory cytokines, leading to immune cell activation.
Besides inducing the transcription of various inflammatory
genes, NF-κB also regulates the activation, differentiation, and
effector function of inflammatory T-cells (Lawrence, 2009;
Liu et al., 2017).
One of the genes that is transcribed by NF-κB activation
is tumor necrosis factor (TNF). TNF is a pro-inflammatory
cytokine that can trigger necroptosis, which is a regulated form
of cell death that shares morphological similarities with necrosis.
It has been observed that CICD has necroptotic features, as
the kinetics of cell death were slowed by genetic alteration
or pharmacological inhibition of the necroptotic pathway.
Inhibiting TNF signaling with Enbrel showed a decrease in
cell death, indicating that TNF is needed to engage necroptosis
in CICD (Giampazolias et al., 2017). TNF is a well-known
activator of NF-κB (Schütze et al., 1992), however, neither TNF
nor the necroptotic pathway is responsible for the activation
of NF-κB during CICD. Rather, we found that the increase
in TNF expression and NF-κB activation during CICD is
wholly dependent on BAX and BAK, indicating that MOMP
is essential for initiating the inflammatory response. Because
of the observation that MOMP is needed to initiate nuclear
translocation of NF-κB in caspase inhibited conditions, we can
conclude that necroptosis is not essential for the activation of
this pathway but accelerates cell death following TNF expression
(Giampazolias et al., 2017).
While NF-κB is robustly activated following MOMP, how
this is initiated is unclear. A logical explanation may relate
to the release of intermembrane space protein SMAC. When
SMAC is present in the cytosol it binds to inhibitor of
apoptosis proteins (IAPs) to block their function (Du et al.,
2000; Verhagen et al., 2000). Besides the role of IAPs to
regulate caspase activity and apoptosis, it is also known
that IAPs are able to modulate inflammatory signaling by
engaging pro-survival NF-κB activation (Gyrd-Hansen and
Meier, 2010). Our lab has shown that upon MOMP, NF-κB
becomes activated through a SMAC-like mechanism, whereby
IAPs are degraded, leading to the activation of NF-κB-inducing
kinase (NIK) (Figure 1). Degradation of IAPs occurs in a
SMAC-like manner since a non-SMAC binding XIAP mutant
is stabilized (Giampazolias et al., 2017). Nevertheless, even
in the absence of known intermembrane space IAP-binding
proteins, SMAC and Omi, IAPs are degraded following MOMP
(Giampazolias et al., 2017). These results demonstrate that
neither SMAC or Omi are required for IAP degradation upon
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MOMP and that some other factor(s) downregulate IAPs in
their absence. Interestingly, recent studies have shown that
IAP-depletion following MOMP also contributes to caspase-8
dependent inflammasome activation in macrophages (Chauhan
et al., 2018; Vince et al., 2018). MOMP-dependent IAP
depletion can therefore promote inflammation by at least two
distinct pathways.
The question remains as to how IAP degradation is
engaged following MOMP. Are proteins in the mitochondrial
intermembrane space responsible for this? Or does it relate
to the permeabilization of the mitochondrial inner membrane,
leading to the release of proteins from the matrix and the inner
mitochondrial membrane into the cytosol? In order to fight
microbial pathogens, the NF-κB pathway is commonly used and
pathogens often interfere with this pathway to escape the immune
response (Rahman and McFadden, 2011). Possibly stemming
from their bacterial ancestry, could it be that mitochondria
have similar pathogen associated molecular patterns (PAMPs)
as invading bacteria, and caspases are capable of silencing the
mitochondrial PAMPs that activate the NF-κB pathway?
CELL DEATH ASSOCIATED
INFLAMMATION: DISEASE RELEVANCE
AND OPEN QUESTIONS
In this mini-review we have described how MOMP can lead
to an inflammatory response in two parallel pathways. MOMP
allows mtDNA to be released into the cytosol, which will
be recognized by cGAS leading to activation of STING. This
allows phosphorylation of IRF3 to occur, inducing a type I
interferon response. In parallel, MOMP leads to the exposure
of factors into the cytosol causing degradation of IAPs in a
SMAC-like manner. IAP downregulation activates NIK and
subsequently NF-κB activation, leading to the transcription
of various cytokines. Several questions remain outstanding:
is mtDNA release regulated? What triggers NF-kB activation
during CICD? How does caspase activity silence inflammation?
Does the immune response only occur in caspase-inhibited
conditions during cell death? Most importantly, what are the
biological roles of these inflammatory effects during apoptotic
cell death?
Although apoptosis is a common cell death mechanism
during embryonic development, the expression of many pro-
apoptotic proteins is reduced in various adult tissues (Sarosiek
et al., 2017). Cardiomyocytes for example do not express
APAF-1 (Sanchis et al., 2003), thereby being unable to form
the apoptosome following MOMP. As a consequence, caspase
activation by cytochrome c is strictly regulated by endogenous
XIAP (Potts et al., 2005). Although cell death is strongly
regulated in cardiomyocytes, apoptosis and necrosis does occur
in hearts when reperfused after myocardial infarction (MI)
(Zhao et al., 2000). Inhibition of caspases in myocardial
ischemia/reperfusion-induced models has shown to limit infarct
size and to improve recovery in rabbit and rat hearts (Holly
et al., 1999; Mocanu et al., 2000; Kovacs et al., 2001).
Even when inhibition of caspases does not fully prevent
cardiomyocytes from dying, the observed clinical improvement
when reperfusion is performed in combination with caspase
inhibition suggests that caspase activity negatively impacts
recovery via an unknown mechanism. It is well established
that during ischemia and reperfusion injury an inflammatory
response is provoked by DAMPs derived from necrotic cells
in the core of the infarct site. These DAMPs help to recruit
leukocytes to the injured areas for cell debris clearance
before heart remodeling can take place (Ong et al., 2018).
In contrast to the necrotic core of the infarct, apoptosis is
primarily observed in the border zone of the infarct (Cheng
et al., 1996; Sarate et al., 1997; Toyoda et al., 1997). It has
been speculated that loss of cells in the border zone has
negative impact on ventricular remodeling (Balsam et al., 2005).
Inhibition of caspases might enhance survival of cardiomyocytes
in the border zone when the extrinsic apoptotic pathway is
activated, however, when MOMP occurs in these cells the
intrinsic apoptotic pathway will still lead to cell death in
the presence of caspase inhibitors. Nevertheless, engaging a
pro-inflammatory response in the border zone through the
release of DAMPs in CICD might have beneficial effects.
Especially DAMP-associated TNF upregulation during CICD
might play a big role in preventing cell loss in the border
zone, as a 50% increase in apoptotic cell death was observed
when a TNF inhibitor was administered in a mice suffering
from MI (Wang et al., 2018). On the other hand, there is
evidence that a type I interferon response, which can potentially
be induced by the release of mtDNA during MI (Wang
et al., 2015), might be harmful as inhibiting this pathway
improves cardiac function and ventricular dysfunction after
MI (King et al., 2017). This indicates that a fine balance
in pro-inflammatory pathways is needed to have a beneficial
effect in MI therapy.
In the context of cancer therapy, it has been described in
multiple studies that apoptosis can have a pro-tumorigenic effect
instead of being anti-tumorigenic (Ichim and Tait, 2016; Cao
and Tait, 2018). One of the implications is that if apoptosis
is not executed properly, it can cause DNA damage and
genomic instability thereby promoting tumor growth (Lovric
and Hawkins, 2010; Ichim et al., 2015; Liu et al., 2015). In
contrast, engaging CICD in subcutaneously injected tumors in
mice causes 50% of the tumors to completely regress. These
tumors showed increased expression of cytokines and T-cell
infiltration, which was completely reversed when T-cells were
depleted in mice, suggesting that the immune system is of
great importance in tumor clearance (Giampazolias et al., 2017).
Specific inhibition of pro-apoptotic caspases improves cancer
cell death by recruiting immune cells to the tumor site. This
shows that there is a potential to significantly improve cancer
therapy by changing the way cells die from an immunosilent to
immunogenic phenotype.
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